Barclays’s Alcentra Capital Corp ABDC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,742
Closed -$13K 7509
2019
Q1
$13K Hold
1,742
﹤0.01% 6501
2018
Q4
$11K Hold
1,742
﹤0.01% 6154
2018
Q3
$10K Hold
1,742
﹤0.01% 6665
2018
Q2
$11K Buy
1,742
+1,696
+3,687% +$11.3K ﹤0.01% 6522
2018
Q1
$0 Hold
46
﹤0.01% 7508
2017
Q4
$0 Sell
46
-48
-51% -$427 ﹤0.01% 7248
2017
Q3
$1K Buy
94
+9
+11% +$103 ﹤0.01% 6802
2017
Q2
$1K Hold
85
﹤0.01% 6570
2017
Q1
$1K Hold
85
﹤0.01% 6692
2016
Q4
$1K Hold
85
﹤0.01% 6536
2016
Q3
$1K Sell
85
-200
-70% -$2.5K ﹤0.01% 6514
2016
Q2
$3K Buy
+285
New +$3.39K ﹤0.01% 5889

Other funds holding ABDC

Barclays's ABDC Position: Q2 2019 in Review

Barclays sold out of Alcentra Capital Corp (ABDC) in Q2 2019, closing a stake of 1,742 shares — an estimated $13K sold.

Barclays first reported a position in ABDC in Q2 2016 and held it in 12 quarters. The position peaked at $13K in Q1 2019. 35 funds tracked by Wall St. Rank hold ABDC as of Q2 2019.

  • Barclays reported no remaining Alcentra Capital Corp position as of Q2 2019 after selling out during the quarter.
  • Barclays sold 1,742 Alcentra Capital Corp shares in Q2 2019, an estimated $13K.
  • Barclays first reported a position in Alcentra Capital Corp in Q2 2016 and held it in 12 quarters.
  • Barclays's Alcentra Capital Corp position peaked at $13K in Q1 2019.
  • 35 funds tracked by Wall St. Rank held Alcentra Capital Corp as of Q2 2019.

Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.